Omics Lab Services Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Omics Lab Services Market Change Between 2026 And 2030?

The omics lab services market size has experienced rapid growth in recent years. It is anticipated to expand from $109.47 billion in 2025 to $126.6 billion in 2026, at a compound annual growth rate (CAGR) of 15.7%. The observed growth in the historic period stems from the expansion of life sciences research activities, growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and the expansion of academic and clinical research collaborations.

The omics lab services market is anticipated to undergo significant expansion in the coming years. Its size is projected to reach $224.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This expansion during the forecast period can be linked to the increased adoption of personalized medicine research, rising investments in systems biology, the broadening availability of AI-enabled bioinformatics tools, a growing need for complete omics solutions, and an intensified focus on data-driven drug discovery. Prominent trends for the forecast period encompass a rising demand for integrated multi-omics analysis, an increased uptake of contract research services, the expansion of bioinformatics-driven data interpretation, greater utilization of high-throughput analytical platforms, and an enhanced emphasis on supporting translational research.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

Which Strategic Drivers Are Supporting The Omics Lab Services Market Development?

The increasing occurrence of genetic illnesses is projected to fuel the expansion of the omics lab services market in the future. These diseases are conditions resulting from anomalies or alterations in an individual’s DNA, which may be inherited or arise without a known cause. The frequency of genetic diseases is increasing because improvements in diagnostic methods, especially next-generation sequencing and other genomic instruments, have greatly enhanced the capacity to discover and pinpoint numerous genetic conditions that were formerly undetected or incorrectly categorized. Omics lab services assist with genetic diseases through the examination of intricate biological data to pinpoint mutations and molecular shifts, thus facilitating early detection and tailored therapeutic approaches. As an illustration, in October 2024, the Cystic Fibrosis Trust, a UK-based charitable organization focused on aiding individuals with cystic fibrosis, reported that 11,148 cystic fibrosis patients were registered in 2022, a figure that climbed to 11,318 in 2023, signifying a 1.5% year-over-year rise in patient registrations. Consequently, the growing incidence of genetic disorders is propelling the expansion of the omics lab services market.

Which Segment-Based Categories Are Covered In The Omics Lab Services Market?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

What Trends Are Driving Changes In The Omics Lab Services Market?

Leading companies in the omeprazole market are developing liquid ready-to-use formulations to boost patient convenience and compliance, especially benefiting individuals who struggle to swallow tablets or capsules. These liquid omeprazole formulations contribute to improved patient adherence, enhanced ease of use, precise dosage delivery, a quicker start of action, and greater medication stability. For example, in February 2024, Alkaloid AD, a pharmaceutical manufacturing firm based in North Macedonia, introduced liquid Omeprazole. This is the first ready-to-use liquid Omeprazole designed for patients with reflux esophagitis and GERD who cannot take tablets, and it incorporates a dual-chamber package. This innovation presents a more practical and accessible treatment choice for patients facing difficulties in swallowing tablets or capsules, such as young children, adults with dysphagia, those with gastric feeding tubes, or geriatric patients. The company has secured the initial international patent for a value-added medicine (VAM) for this product and has been granted marketing authorizations for both the Macedonian and UK markets.

Which Companies Are Engaged In The Omics Lab Services Market Environment?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Access The Complete Omics Lab Services Market Report:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Region Contributes The Most To The Omics Lab Services Market?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Omics Lab Services Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Olanzapine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Proton Pump Inhibitors Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

Clopidogrel Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795